Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktoria Anfang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 27, 2022
Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDiona Gjermeni, Hannah Vetter, Sofia Szabó, et al.
Thrombosis Journal|May 21, 2024
D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary interventionDiona Gjermeni, Viktoria Anfang, Sofia Szabó, et al.
Journal of Cardiovascular Translational Research|August 27, 2025
Platelet Reactivity and Fibrin Clot-Strength as assessed by TEG in Patients with Atrial Fibrillation undergoing Percutaneous Coronary InterventionDiona Gjermeni, Hannah Vetter, Sofia Szabó, et al.
Clinical and Translational Science|May 19, 2026
CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCIDiona Gjermeni, Sofia Szabó, Viktoria Anfang, et al.
Journal of Thrombosis and Thrombolysis|February 12, 2024
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot studyDiona Gjermeni, Viktoria Anfang, Hannah Vetter, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 27, 2022
Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDiona Gjermeni, Hannah Vetter, Sofia Szabó, et al.
Thrombosis Journal|May 21, 2024
D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary interventionDiona Gjermeni, Viktoria Anfang, Sofia Szabó, et al.
Journal of Cardiovascular Translational Research|August 27, 2025
Platelet Reactivity and Fibrin Clot-Strength as assessed by TEG in Patients with Atrial Fibrillation undergoing Percutaneous Coronary InterventionDiona Gjermeni, Hannah Vetter, Sofia Szabó, et al.
Clinical and Translational Science|May 19, 2026
CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCIDiona Gjermeni, Sofia Szabó, Viktoria Anfang, et al.
Journal of Thrombosis and Thrombolysis|February 12, 2024
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot studyDiona Gjermeni, Viktoria Anfang, Hannah Vetter, et al.
Pageof 1